GlaxoSmithKline Pharmaceuticals Limited -1.78 % Drug Manufacturers - Major

Trend Analysis


Support and Resistance Levels Analysis
The current close value 1371.6 is between the support and resistance channel of 1362 and 1392. The stock has a Sell Signal , 1362 becomes a critical support to stop the fall and 1392 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 1384.0
MACD value -8.7
Price range 1324.10 to 1515.35
Volume range 9033 to 23440
Support & Resistance 1362, 1392
Stock Performance
Six Months -60.0%
Five Months-5.4%
Four Months6.5%
Three Months1.5%
Two Months-5.1%
One Month-3.3%
Last Six Months


Last Five Months


Last Four Months


Last Three Months


Last Two Months


Last One Month


Today's Price Range
3 Month Price Range
About GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited is a healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company's product portfolio includes prescription medicines and vaccines. The Company's prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The Company also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The Company's dermatology brands include Betnovate, TBact and Tenovate, and cosmetology brands include Ansolar, Oilatum and Physiogel.
See stocks similar to GlaxoSmithKline Pharmaceuticals Limited in Drug Manufacturers - Major

GlaxoSmithKline Pharmaceuticals Limited has Sell Signal. What is your opinion on it?

{ }